ALIM Company Profile and Key Details
Alimera Sciences, Inc.
ALIM Stock Price Chart
Stock Price Today
Alimera Sciences, Inc. (ALIM) stock declined over -0.18%, trading at $5.54 on NASDAQ, down from the previous close of $5.55. The stock opened at $5.55, fluctuating between $5.53 and $5.56 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Company Information
| Employees | 154 |
| Beta | 1.25 |
| Sales or Revenue | $80.75M |
| 5Y Sales Change% | -0.686% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Alimera Sciences, Inc. (NASDAQ: ALIM) stock price is $5.54 in the last trading session. During the trading session, ALIM stock reached the peak price of $5.56 while $5.53 was the lowest point it dropped to. The percentage change in ALIM stock occurred in the recent session was -0.18% while the dollar amount for the price change in ALIM stock was -$0.01.
The NASDAQ listed ALIM is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Alimera Sciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Charles Daniel Myers
Non-Executive Chairman & Consultant
Mr. John Philip Jones
Chief Financial Officer
Christopher S. Visick
Vice President, Gen. Counsel & Sec.
Mr. Richard S. Eiswirth Jr.
Pres, Chief Executive Officer & Director
Dr. Philip Ashman Ph.D.
Chief Operating Officer & Senior Vice President of Commercial Operations - Europe
Mr. Russell L. Skibsted M.B.A.
Senior Vice President & Chief Financial Officer
Mr. David R. Holland
Co-Founder, Chief Marketing Officer and Senior Vice President of Corporation Communications & Managed Markets
Dr. David Dyer M.D.
Chief Retina Specialist
ALIM's closing price is 112.59% higher than its 52-week low of $2.61 where as its distance from 52-week high of $5.65 is -1.95%.
Number of ALIM employees currently stands at 154.
Official Website of ALIM is: https://alimerasciences.com
ALIM could be contacted at phone 678 990 5740 and can also be accessed through its website. ALIM operates from 6310 Town Square, Alpharetta, GA 30005, United States.
ALIM stock volume for the day was 2.68M shares. The average number of ALIM shares traded daily for last 3 months was 866.83K.
The market value of ALIM currently stands at $301.29M with its latest stock price at $5.54 and 54.38M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com